Article

Preferences for genetic interventions for SCA and Huntington’s disease: results of a discrete choice experiment among patients.

2024-01-10

Abstract excerpt

<title>Abstract</title> <p><bold>Background</bold> Although genetic interventions are on the horizon for some polyglutamine expansion diseases, such as subtypes of spinocerebellar ataxia (SCA) and Huntington’s disease (HD), the patients’ preferences regarding these new therapies are unclear. This study aims to what extent different characteristics of genetic interventions affect the preferences of patients with S...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: edb7d729-a552-5596-93f7-8eb8e3ebb544
DOI: 10.21203/rs.3.rs-3576801/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Preferences for genetic interventions for SCA and Huntington’s disease: results of a discrete choice experiment among patients.DOI 10.21203/rs.3.rs-3576801/v1Read

Treatment preference among patients with spinal muscular atrophy (SMA): a discrete choice experimentSemantic proximity Read

Measuring preferences for CYP2C19 genotyping in patients with acute coronary syndrome - a discrete choice experiment.Semantic proximity Read

Public Preferences for Digital Therapies in Alzheimer's Disease Treatment: A Discrete Choice Experiment in ChinaSemantic proximity Read

Public Preferences for Genetic and Genomic Risk-Informed Chronic Disease Screening and Early Detection: A Systematic Review of Discrete Choice Experiments.Semantic proximity Read

Using a Discrete Choice Experiment to Examine the Factors Influencing Clinical Trial Participation in a Nationally Representative SampleSemantic proximity Read

PREFER-DMT: A Discrete Choice Experiment Framework for Eliciting Stakeholder Preferences on Disease-Modifying Therapy Implementation in European Healthcare SystemsSemantic proximity Read

Designing national programs for expanded carrier screening: Results from a discrete-choice experiment in SingaporeSemantic proximity Read

Is it ethical to reimburse “SMA Innovative Treatments” from government resources?Semantic proximity Read

Methodology to Derive Preference for Health Screening Programmes Using Discrete Choice Experiments: A Scoping ReviewSemantic proximity Read

Lessons for clinical trial design in Friedreich's ataxia.Semantic proximity Read

Genetic variability and potential effects on clinical trial outcomes: perspectives in Parkinson’s diseaseSemantic proximity Read

The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS studySemantic proximity Read